SavedAdd your journal

Journals / Türk Kadın Sağlığı ve Neonatoloji Dergisi / 2020 / Cilt: 2 - Sayı: 4

Management of hypoactive sexual desire disorder

Hipoaktif cinsel istek bozukluğunun yönetimi

Yeşim BAYOĞLU TEKİN
Kübra BAKİ ERİN
Pages
133–139
Publication Date
2020-12-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

If there is no response after these steps, medical treatment should be applied.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hypoactive sexual desire disorder is the most common female sexual dysfunction.
📊
Key Findings & Data:This review aimed to screen for decreased sexual desire in women with sexual dysfunction and determine which cases need treatment.
💡
Conclusion & Impact:If there is no response after these steps, medical treatment should be applied.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Hipoaktif Cinsel İstek Bozukluğu · kadında cinsel fonksiyon bozuklukları · azalmış cinsel arzu

Abstract

Hypoactive sexual desire disorder is the most common female sexual dysfunction. This review aimed to screen for decreased sexual desire in women with sexual dysfunction and determine which cases need treatment. Detailed medical and sexual history is the most critical step in guiding the treatment. Laboratory tests gain importance in the differential diagnosis. Initial treatment should include education, counselling and behavioral therapy. Modification of contributing factors is essential. If there is no response after these steps, medical treatment should be applied.

Özet

Hipoaktif cinsel istek bozukluğu kadınlarda en sık görülen cinsel istek bozukluğudur. Bu derlemede cinsel fonksiyon bozukluğu olan kadınlarda azalmış cinsel arzuya yönelik olarak tarama yapılması ve hangi durumlarda kişinin tedaviye ihtiyacı olduğunun belirlenmesi amaçlanmaktadır. Ayrıntılı tıbbi ve seksüel öykü tedavinin yönlendirilmesinde en önemli basamaktır. Laboratuvar testleri ayırıcı tanıda önem kazanmaktadır. Tedavi basamaklarında öncelikli olarak hastaya eğitim ve danışmanlık verilmesi ve davranışsal terapi uygulaması ile başlanmalıdır. Etki eden faktörlerin modifikasyonu önemlidir. Bu basamaklardan sonra yanıt alınamazsa medikal tedavi uygulanmalıdır.

🔖

Cite This Article

TEKİN, Y. B., ERİN, K. B. (2020). Management of hypoactive sexual desire disorder. Türk Kadın Sağlığı ve Neonatoloji Dergisi, Cilt: 2 - Sayı: 4, 133–139. https://ajindex.com/articles/811682

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Sungur MZ, Gunduz A. A comparison of DSM-IV-TR and DSM-5 definitions for sexual dysfunctions: critiques and challenges. J Sex Med 2014; 11:364–373.
  2. Clayton AH, Goldstein I, Kim NN et al. The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women. Mayo Clin Proc 2018; 93:467-487.
  3. Clayton AH, Valladares Juarez EM. Female Sexual Dysfunction. Med Clin N Am 2019; 103:681–698.
  4. Goldstein I, Kim NN, Clayton AH, et al. Hypoactive sexual desire disorder: International Society for the Study of Women’s Sexual Health (ISSWSH) expert consensus panel review. Mayo Clin Proc 2017; 92:114-128.
  5. Clayton AH, Goldfischer ER, Goldstein I, Derogatis L, Lewis- D’Agostino DJ, Pyke R. Validation of the Decreased Sexual Desire Screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). J Sex Med 2009; 6:730-738.
  6. Maserejian NN, Shifren J, Parish SJ, Segraves RT, Huang L, Rosen RC. Sexual arousal and lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the Hypoactive Sexual Desire Disorder Registry for Women. J Sex Marital Ther 2012; 38:41-62.
  7. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005; 90:3847-3853.
  8. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Mühlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: The Rancho Bernardo Study. J Clin Endocrinol Metab 2000; 85:645-651. Clayton AH. Female sexual dysfunction related to depression and antidepressant medications. Curr Womens Health Rep 2002; 2:182-187.
  9. Johannes CB, Clayton AH, Odom DM, et al. Distressing sexual problems in United States women revisited: prevalence after accounting for depression. J Clin Psychiatry. 2009;70(12):1698-1706.
  10. Maseroli E, Fanni E, Cipriani S, et al. Cardiometabolic risk and female sexuality: focus on clitoral vascular resistance. J Sex Med 2016; 13:1651-1661.
  11. Panjari M, Bell RJ, Davis SR. Sexual function after breast cancer. J Sex Med 2011; 8:294-302.
  12. Fobair P, Spiegel D. Concerns about sexuality after breast cancer. Cancer 2009; 15:19-26.
  13. Zimmerman Y, Eijkemans MJ, Coelingh Bennink HJ, Blankenstein MA, Fauser BC. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Hum Reprod Upda